Breast regimen-specific consent forms

Dear All,

 

I am pleased to inform you that the breast regimen-specific consent forms have been updated with the following:

  • Subcutaneous administration option for regimens containing Trastuzumab  and Pertuzumab.
  • Standard  statement on alcohol to regimens containing Gemcitabine and Paclitaxel.
  • Standard statement indicating the risk of diabetes with SACT treatment, including those where steroids are in the protocol for anti-emetic/allergy.

The forms are available via CRUK website at: www.cruk.org/sact_consent.

Please forward to your colleagues.

Any questions please let me know.

 

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Guy’s and St Thomas’ NHS Foundation Trust

Guy’s Hospital | Great Maze Pond | London | SE1 9RT
SACT regimen-specific consent forms: www.cruk.org/sact consent |

Our values: Put patients first | Take pride in what we do | Respect others | Strive to be the best | Act with integrity

 

Latest News

By Suriya Marshall on 19th June 2026

Inclusion in Action: Cancer Pharmacy Champion – EDI award nominations 2026

Inclusion in Action: Cancer Pharmacy Champion – EDI award nominations We’re pleased to launch the BOPA EDI Excellence Award, recognising individuals and teams who are actively advancing equity, diversity and inclusion in cancer pharmacy. This…

Read article
By Suriya Marshall on 19th June 2026

BOPA Above & Beyond Awards 2026

The Above and Beyond Award celebrates individuals and teams going over and above what is expected of them in the workplace. It is to celebrate those achievements of BOPA members…

Read article
By BOPA Executive Committee on 16th June 2026

BOPA Fellowship Nominations 2026 are NOW OPEN!

We are pleased to announce that BOPA Fellowship Nominations have now opened for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing…

Read article
By Pharmaceutical Press (PhP) on 15th June 2026

Exciting new project with the Pharmaceutical Press (PhP)

Expressions of interest: We are currently seeking expressions of interest to support an exciting new project with the Pharmaceutical Press (PhP). PhP is developing a new resource to support healthcare…

Read article